TITLE

Fine Lines

AUTHOR(S)
Sullivan, Andrew
PUB. DATE
March 2001
SOURCE
New Republic;03/05/2001, Vol. 224 Issue 10, p8
SOURCE TYPE
Periodical
DOC. TYPE
Editorial
ABSTRACT
Focuses on issues related to war on drugs in the United States. Questions that surround the so-called war on drugs and ambiguity of the term "drugs"; Efforts to regulate medicinal, as well as recreational drugs; Side effects of legal drugs, such as caffeine and serotonin, as compared with those of Ecstasy and heroin; Suggestion that all drugs need to be controlled, not just the drugs of abuse that are regularly targeted by the drug war.
ACCESSION #
4133273

 

Related Articles

  • CLUB DRUGS: destination x.  // Club Drugs: Destination X;Oct2007, p1 

    The article offers information on various drugs, including ecstasy, ketamine, and 2 C-B that are being increasingly used by the people of generation Y. It mentions that the drug ecstasy is considered a party drug and is used by people who party regularly. Ketamine is medically used as an...

  • Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users. McCann, U. D.; Eligulashvili, Victoria; Mertl, Melissa; Murphy, Dennis L.; Ricaurte, George A. // Psychopharmacology;1999, Vol. 147 Issue 1, p56 

    Abstract Rationale: (+/-) 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") is a popular drug of abuse and a brain serotonin neurotoxin in animals. Growing evidence indicates that humans are also susceptible to MDMA's neurotoxic effects, although few functional consequences of MDMA-induced...

  • A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Schifano, Fabrizio // Psychopharmacology;2004, Vol. 173 Issue 3/4, p242 

    Rationale. The issue of ecstasy-related fatalities has extensively attracted the attention of both the media and the general public, but less so of the scientific literature. Objectives. The aim of the present review is to focus on the epidemiological, clinical and pharmacological issues related...

  • Methylenedioxymetamfetamine/moclobemide interaction.  // Reactions Weekly;8/22/2009, Issue 1266, p23 

    The article describes the cases of three patients who experienced fatal serotonin syndrome while receiving moclobemide and recreational methylenedioxymetamfetamine (MDMA). Particular focus is given to the MDMA concentration found in the patients, as well as their autopsy findings. The author...

  • Adrenergic receptor agonists/dihydroergotamine mesilate/fentanyl.  // Reactions Weekly;5/24/2008, Issue 1203, p6 

    The article describes the case of a 25-year-old man who acquired serotonin syndrome. The patient developed the condition after he was administered with illicit methylenedioxymetamfetamine, ephedrine, dihydroergotamine mesilate for migraine and intrathecal fentanyl as anaesthesia. He was treated...

  • Dr David Bull explains…illegal drugs. Bull, David // Gay Times (09506101);Aug2010, Issue 383, p96 

    The article provides information on several illegal drugs. An individual caught with cocaine can be imprisoned up to seven years. It is very addictive and effective stimulant. Ecstasy is a white powder or tablet in form which can be snorted or smoked. Mephedrone makes an individual feel more...

  • Move Over Prozac, It's Ecstasy's Turn. Spun, Brandon // Insight on the News;4/15/2002, Vol. 18 Issue 13, p18 

    Reports on the promotion of the of methylenedioxymethampethamine (MDMA) or ecstasy as a treatment for depression. Side-effects of psychotropic drugs; Difference of MDMA with serotonin selective reuptake inhibitors; Views on medicating society with psychotropics and other drugs.

  • Ecstasy downer.  // New Scientist;3/12/2005, Vol. 185 Issue 2490, p5 

    This article reports that ecstasy appears to trigger depression in people with a genetic susceptibility to the condition. Ecstasy tricks neurons into dumping large quantities of the mood-regulating neurotransmitter serotonin into the brain. David Rubinsztein and colleagues at the University of...

  • Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') users. McCann, Una; Edwards, Robert; Smith, Michael; Kelley, Kristen; Wilson, Michael; Sgambati, Francis; Ricaurte, George // Psychopharmacology;Oct2011, Vol. 217 Issue 4, p475 

    Rationale: (±)3,4-Methylenedioxymethamphetamine (MDMA) is a popular recreational drug that has potential to damage brain serotonin (5-HT) neurons in humans. Brain 5-HT neurons play a role in pain modulation, yet little is known about long-term effects of MDMA on pain function. Notably, MDMA...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics